Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation. | Biomed Res Int | 2022 | 35865667 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Analysis Reveals Mesenchymal Stem Cells in Cavernous Hemangioma. | Front Cell Dev Biol | 2022 | 35865633 | PubTator, text mining | PubMed |
| Chromatin Methylation Abnormalities in Autosomal Dominant Polycystic Kidney Disease. | Front Med (Lausanne) | 2022 | 35865176 | PubTator, text mining | PubMed |
| G protein-coupled receptor interactions with arrestins and GPCR kinases: The unresolved issue of signal bias. | J Biol Chem | 2022 | 35863432 | PubTator, text mining | PubMed |
| LRBA is essential for urinary concentration and body water homeostasis. | Proc Natl Acad Sci U S A | 2022 | 35862451 | PubTator, text mining | PubMed |
| Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases. | Front Cardiovasc Med | 2022 | 35859595 | PubTator, text mining | PubMed |
| Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease. | Drugs | 2022 | 35852784 | PubTator, text mining | PubMed |
| Structural basis for the activation and ligand recognition of the human oxytocin receptor. | Nat Commun | 2022 | 35851571 | PubTator, text mining | PubMed |
| Therapeutic Potential of a Vasopressin V2 Receptor Antagonist for Calcium Channel Blocker-Associated Edema with Vasospastic Angina. | Case Rep Cardiol | 2022 | 35845175 | PubTator, text mining | PubMed |
| Cilia-Localized Counterregulatory Signals as Drivers of Renal Cystogenesis. | Front Mol Biosci | 2022 | 35832738 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the potential regulatory mechanisms of renal fibrosis and the screening and identification of factors related to human renal fibrosis. | Transl Androl Urol | 2022 | 35812190 | PubTator, text mining | PubMed |
| Effects of vasopressin receptor agonists on detrusor smooth muscle tone in young and aged bladders: Implications for nocturia treatment. | Continence (Amst) | 2022 | 35789681 | PubTator, text mining | PubMed |
| Cas-Based Systems for RNA Editing in Gene Therapy of Monogenic Diseases: In Vitro and in Vivo Application and Translational Potential. | Front Cell Dev Biol | 2022 | 35784464 | PubTator, text mining | PubMed |
| Notch signaling determines cell-fate specification of the two main types of vomeronasal neurons of rodents. | Development | 2022 | 35781337 | PubTator, text mining | PubMed |
| Michaelis-Menten Quantification of Ligand Signaling Bias Applied to the Promiscuous Vasopressin V2 Receptor. | Mol Pharmacol | 2022 | 35779859 | PubTator, text mining | PubMed |
| Reversible Photoinduced Conversion of Unprecedented Norbornadiene-Based Photoswitches with Redox-Active Naphthalene Diimide Functionalities. | Chemistry | 2022 | 35776126 | PubTator, text mining | PubMed |
| Design and Functional Analysis of Heterobifunctional Multivalent Phage Capsid Inhibitors Blocking the Entry of Influenza Virus. | Bioconjug Chem | 2022 | 35759354 | PubTator, text mining | PubMed |
| Sodium-glucose cotransporter inhibition in polycystic kidney disease: fact or fiction. | Clin Kidney J | 2022 | 35756735 | PubTator, text mining | PubMed |
| Relative Frequencies of PAX6 Mutational Events in a Russian Cohort of Aniridia Patients in Comparison with the World's Population and the Human Genome. | Int J Mol Sci | 2022 | 35743132 | PubTator, text mining | PubMed |
| Emerging structural insights into GPCR-β-arrestin interaction and functional outcomes. | Curr Opin Struct Biol | 2022 | 35738165 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=26